PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 330 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | -99.9% | 330 | -99.9% | 0.00% | -100.0% |
| Q1 2015 | $3,165,000 | -48.5% | 449,930 | -43.6% | 0.72% | -58.3% |
| Q4 2014 | $6,151,000 | -1.2% | 797,830 | -4.2% | 1.74% | -3.1% |
| Q3 2014 | $6,223,000 | +142.0% | 833,030 | +213.5% | 1.79% | +154.5% |
| Q2 2014 | $2,572,000 | – | 265,730 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |